Menu
Recruiting NCT05133024

Use of Beetroot Juice to Protect Against Postoperative Ileus Following Colorectal Surgery: BEET IT Study

Phase II Interventional Postoperative Ileus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: concentrated beetroot juice.
Who it may be relevant to
Registry conditions: Postoperative Ileus. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of the BEET IT study is to examine if preoperative intake of beetroot juice can ameliorate gastrointestinal (GI) recovery after colorectal surgery and thereby help to reduce the duration of postoperative ileus (POI) and prevent prolonged POI. Adult patients undergoing laparoscopic colorectal surgery are randomized 1:1 to consume either concentrated beetroot juice (active intervention) or nitrate-depleted concentrated beetroot juice (placebo) during the week before their surgery. Blood, tissue and/or fecal samples are collected at specific time points pre- and/or postoperatively to study markers related to inflammation, oxidative stress and GI function. Patients are followed from the week before surgery (start of the intervention) until 3 months post-surgery. The study takes place at 5 hospitals in Flanders, Belgium.

Detailed description

Postoperative ileus (POI), a transient impairment of gastrointestinal (GI) motility, remains one of the most common complications following abdominal surgery. It is characterized by the presence of nausea and vomiting, the inability to tolerate oral diet, abdominal distension and delayed passage of flatus and stool. POI usually resolves within 3 to 5 days, but when prolonged, it can lead to increased morbidity, prolonged hospitalization and increased healthcare costs. In patients undergoing colorectal surgery, the reported incidence of prolonged POI (PPOI) is 10.2%. Prevention and treatment remains mainly supportive and no single effective treatment is currently available. Because of its multifactorial origin and possible exogenous factors, prevention and treatment generally requires a multimodal approach. Many of these strategies are part of the Enhanced Recovery after Surgery (ERAS) program. The pathophysiology of POI is marked by an acute neurogenic phase followed by a prolonged inflammatory phase and alterations in the enteric neurotransmission. The pathogenesis involves inflammation and oxidative stress, similar to ischemia/reperfusion (I/R) injury. Both I/R injury and POI are associated with downregulation of nitric oxide (NO) synthases. In this sense, beetroot juice holds considerable promise. Beetroot is a rich source of inorganic nitrate. Consumption of nitrate-rich foods increases the concentration of NO metabolites in the blood and tissues via the enterosalivary nitrate-nitrite-NO pathway, independently of the traditional pathway via the endogenous NOS enzymes, which tends to become less effective in older age and in environments wherein oxygen availability is limited such as during hypoxia and I/R injury. Interest goes to the effects of preoperative beetroot juice supplementation on postoperative GI recovery and POI duration after laparoscopic colorectal surgery. A proof of concept study with 12 patients at our lab already showed promising results. We now want to validate the results in a bigger group of patients via a multicentric double-blind randomized controlled prospective phase II study.

Interventions

  • Dietary supplement concentrated beetroot juice
    Nitrate supplementation; natural source of dietary nitrate

Primary outcome measures

  • Postoperative recovery of gastrointestinal (GI) function [Time frame: hours after the end of surgery (suture)]
Secondary outcome measures (9)
  • First passage of flatus [Time frame: first occurence after the end of surgery (suture)]
  • First passage of stool [Time frame: first occurence after the end of surgery (suture)]
  • First tolerance of liquids [Time frame: first occurence after the end of surgery (suture)]
  • First tolerance of a semi-solid diet [Time frame: first occurence after the end of surgery (suture)]
  • First tolerance of a solid diet [Time frame: first occurence after the end of surgery (suture)]
  • Incidence and recovery of PPOI [Time frame: until hospital discharge after surgery]
  • Postoperative length of hospital stay [Time frame: until hospital discharge after surgery]
  • Number and types of postoperative complications [Time frame: until 3 months after surgery]
  • Levels of specific biomarkers in blood, tissues and/or feces [Time frame: 4 time points: (1) inclusion, (2) day of surgery, (3) postoperative day 1, (4) postoperative day 3]

Eligibility criteria

Inclusion criteria

  • Adult patients undergoing elective colonic and upper rectum laparoscopic surgery requiring an anastomosis, without the need of conversion

Exclusion criteria

General:

  • < 18 years of age
  • Pregnancy or breast feeding

Medical:

  • Psychiatric pathology capable of affecting comprehension and judgment faculty
  • History of inflammatory bowel disease
  • Chronic vascular disease affecting the intestines
  • Chronic constipation (<= 2 bowel movements/week)
  • Previous abdominal or pelvic radiation treatment
  • Recent (< 3 months before inclusion) or current intra-abdominal infection or inflammation (e.g. diverticulitis, appendicitis, cholecystitis)
  • Use of gut motility influencing agents (e.g. tricyclic antidepressants, chronic use of laxatives)
  • Use of nitrates (e.g. isosorbide dinitrate, nitroglycerin), including daily consumption of beetroot juice (unless stopped for a month prior to the intervention period)
  • Hypotension (< 100/60 mmHg)
  • Uncontrolled diabetes mellitus
  • Renal or hepatic insufficiency
  • Known allergies or intolerances to beetroot, nitrates/nitrites
  • Enrollment in other clinical trials/experiments, unless approved by the Ethics Committee(s)

Surgical:

  • History of prior colorectal surgery
  • Emergency surgery
  • Open surgery
  • Colorectal surgery not requiring an anastomosis (e.g. colotomy, wedge resection)
  • More than 1 bowel anastomosis planned
  • Concomitant surgical procedures required (e.g. resection of liver or lung metastases)
  • Protective stoma planned

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Quadruple blind
Primary purpose
Prevention

Study locations

Belgium · 6 centers
  • Antwerp University Hospital — Edegem
  • Hospital East-Limburg — Genk
  • AZ Sint-Lucas Ghent — Ghent
  • Ghent University Hospital — Ghent
  • University Hospital Leuven — Leuven
  • VITAZ — Sint-Niklaas

Identifiers

NCT: NCT05133024 · BC-06366

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗